Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 17,000 | |||
10 mg | 在庫あり | ¥ 28,500 | |||
25 mg | 在庫あり | ¥ 57,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 19,000 |
説明 | Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6. |
In vitro | The anti-liver cancer activity of GCM using both in vitro and in vivo models and found for the first time that GCM possesses a potent activity against liver cancer evidenced by cell growth inhibition and apoptosis induction in vitro and tumor reduction in vivo. Mechanistically, GCM was able to bind to and inactivate oncogenic kinase T-LAK cell-originated protein kinase (TOPK), which in turn led to activation of p53 pathway[1] |
植物由来 |
分子量 | 368.38 |
分子式 | C21H20O6 |
CAS No. | 94805-82-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 18.42mg/mL (50mM), Sonification/heating is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glycycoumarin 94805-82-0 Autophagy Chromatin/Epigenetic MAPK Metabolism PI3K/Akt/mTOR signaling P450 JNK AMPK inhibit Inhibitor inhibitor